News

Solara Active Pharma Sciences Limited will close its trading window for securities transactions starting Thursday, October 1, 2026, and continuing for 48 hours after the announcement of financial results for the quarter and half year ending September 30, 2026, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Solara Active Pharma Sciences Limited announced the allotment of 2,250 equity shares following the exercise of options under its Solara Employee Stock Option Plan 2018, according to a filing with the BSE Limited and the National Stock Exchange of India Limited on August 18, 2026. The company`s board approved the allotment, which was executed on June 28, 2024, and resulted in a paid-up share capital increase to Rs 48,05,79,964.50. The exercise price per share was Rs 375, generating Rs 8,43,750 for the company.

Net profit of Solara Active Pharma Sciences rose 55.04% to Rs 16.31 crore in the quarter ended June 2026 as against Rs 10.52 crore during the previous quarter ended June 2025. Sales rose 19.57% to Rs 381.60 crore in the quarter ended June 2026 as against Rs 319.15 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales381.60319.15 20 OPM %16.2417.87 - PBDT43.0234.10 26 PBT16.3110.52 55 NP16.3110.52 55 Powered by Capital Market - Live News

Solara Active Pharma Sciences has appointed Ajit Manocha as Chief Information Officer (CIO) with effect from 10 August 2026.

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company on 23 July 2026.